Micro-Coring® for the Treatment of Skin Laxity of the Knees

Inclusion Criteria: * Male or female age 22 to 70 * With lax skin over one or both knees, physician discretion * Able to provide written informed consent, understand and willing to comply with all study related procedures and follow-up visits * Fitzpatrick Skin Type I to VI as evaluated by the Investigator Exclusion Criteria: * Pregnant women or nursing mothers * Body mass index \> 30 · Patients with dermatosis, open wounds, sores, or irritated skin in the treatment area * Patients with allergy to stainless steel or to topical, oral, or injected medications or preparations that may be used during the procedure, such as petrolatum, lidocaine, bupivacaine, chlorhexidine, or povidone-iodine * Patients with a history or presence of any clinically significant bleeding disorder * Patients with dermatological or autoimmune conditions that may affect the treatment outcome; these may include, but are not limited to: actinic keratosis, raised nevi, rosacea, melasma, active acne, cutaneous papules/nodules, active inflammatory lesions, dermatitis, psoriasis, cellulitis, urticarial folliculitis, acute inflammatory phase of scleroderma, rheumatoid arthritis, eczema, psoriasis, allergic dermatitis, collagen disorders, or lupus * Patients with systemic infections or acute local skin infections (as Hepatitis disorders type A, B, C, D, E or F or HIV infection) * Patients who are on a high dose of anti-coagulants or blood-thinning substances, e.g., aspirin \> 150 mg/day, nonsteroidal anti-in…